- £100.49m
- £84.87m
- £23.70m
- 73
- 15
- 52
- 41
REG - Diaceutics PLC - Revenue growth of 24% in H1 with 55% now recurring
AnnouncementREG - Diaceutics PLC - Senior Management Appointments
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/SIP and Total Voting Rights
AnnouncementREG - Diaceutics PLC - Result of AGM
AnnouncementRCS - Diaceutics PLC - "Precision Medicine in Oncology " Virtual Event
AnnouncementREG - Diaceutics PLC - Diaceutics - Capital Markets Event
AnnouncementREG - Diaceutics PLC - Notice of AGM and Posting of Annual Report
AnnouncementREG - Diaceutics PLC - Data to be Presented at 2024 ASCO Annual Meeting
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/SIP and Total Voting Rights
AnnouncementREG - Diaceutics PLC - Director / PDMR Shareholding
AnnouncementREG - Diaceutics PLC - Revenue growth of 22% & order book growth of 57%
AnnouncementREG - Diaceutics PLC - Two New Enterprise-Wide Engagements
AnnouncementREG - Diaceutics PLC - Diaceutics - Capital Markets Event
AnnouncementREG - Diaceutics PLC - Notice of Results & Presentations
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/SIP and TVR
AnnouncementREG - Diaceutics PLC - Appointment of Amie Mc Neice as VP of Marketing
AnnouncementREG - Diaceutics PLC - Block Listing Return
AnnouncementREG - Diaceutics PLC - PDMR Shareholding/Share Incentive Plan
AnnouncementREG - Diaceutics PLC - Director/PDMR/PCA Shareholding & TR1
Announcement